跳至主要内容
临床试验/NCT05926622
NCT05926622招募中不适用

Clinical and Radiological Outcomes of Medacta Shoulder System

Medacta International SA1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Survival Rate

研究概览

简要总结

This is a post-marketing surveillance on Medacta Shoulder System

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 18 years
  • Patient with one of the following diagnosis:
  • Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty

排除标准

  • Patients with malignant diseases (at the time of surgery)
  • Patients with proven or suspect infections (at the time of surgery)
  • Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery)
  • Patients with known incompatibility or allergy to products materials (at the time of surgery)

结局指标

主要结局

Survival Rate

时间窗: 10 years

Kaplan Meier method

次要结局

  • Adverse events(up to 10 years)
  • Clinical outcome evaluating Constant & Murley Score(1, 2, 5 and 10 years)
  • Radiographic performance of the implants evaluating presence of radiolucencies(3 months, 1, 2, 5 and 10 years)
  • Functional outcome evaluating Oxford Shoulder Score(1, 2, 5 and 10 years)
  • Patient evaluation quality of life(1, 2, 5 and 10 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验